The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder
Introduction
Clinically autism spectrum disorders (ASD), schizophrenia (SCZ), bipolar disorder (BD) and obsessive-compulsive disorder (OCD) differ substantially in that they not only fall into different categories of the DSM (American Psychiatric Association, 2013), but also differ in age of onset, neurocognitive profiles and neuroimaging (American Psychiatric Association, 2013). Genetically, however, they might be more similar in a broader sense (psychiatric disorders) whereby common symptom overlap might be somewhat attributable to common underlying molecular mechanisms (Carroll and Owen, 2009; Khanzada et al., 2017). Research supports this theory in that a number of independent single disorder genome-wide association studies (GWAS) have identified the same significant loci regardless of disorder (Consortium et al., 2013), and a number of cross-disorder case-control GWAS association studies have yielded significant results (Carroll and Owen, 2009). Similar behavioural, social, cognitive and perceptual disturbances are observed in individuals suffering from ASD, SCZ, BD and OCD (American Psychiatric Association, 2013; Vannucchi et al., 2014), while molecular overlap, at both genetic and transcriptomic levels, has been identified for the aetiology of SCZ, BD and ASD (Carroll and Owen, 2009; Gandal et al., 2016; Khanzada et al., 2017), and suggested for ASD and OCD (Jacob et al., 2009). Considering the latter, the exact molecular mechanisms that OCD may share with ASD have not been described, while unpublished results suggest molecular overlap between OCD, SCZ and BD (Anttila et al., 2017).
In addition to the molecular overlap described above, clinical evidence further suggests common aetiology for neuropsychiatric disorders. Individuals affected by OCD and SCZ show similar age-related reductions in white matter connectivity, with overlapping spatial pattern deficits, suggesting common neurobiology (Hawco et al., 2016). Obsessive-compulsive behaviors are present in some ASD affected individuals (Cath et al., 2008), while individuals suffering from OCD have increased comorbid diagnoses of both SCZ and BD (Cederlöf et al., 2015), as well as ASD traits (Ivarsson and Melin, 2008), further suggesting common aetiology for these neuropsychiatric disorders. Despite evidence to suggest common aetiology for these neuropsychiatric disorders they present with distinct clinical profiles, suggesting that each must have a corresponding unique genetic architecture.
This study aims to characterise the common and unique molecular architecture of ASD, SCZ, BD and OCD by analysing previously identified associations with the aforementioned neuropsychiatric disorders.
Section snippets
Materials and methods
Gene lists were obtained from previously published studies for ASD (number of genes, n = 792) (Butler et al., 2015), BD (number of genes, n = 291) (Douglas et al., 2016), SCZ (number of genes, n = 560) (Butler et al., 2016), and OCD (number of genes, n = 153; OCDB) (http://alpha.dmi.unict.it/ocdb/; accessed 31 May 2017) (Privitera et al., 2015). These disorders were selected for investigation due to the evidence outlined in the introduction above and the public availability of the gene datasets
Gene list summary statistics
Ten genes were identified to be commonly associated with the aetiology of ASD, SCZ, BD and OCD (BDNF, CACNA1C, CHRNA7, DRD2, HTR2A, MAOA, MTHFR, NOS1AP, SLC6A3 and TPH2). In contrast, a large number of previously associated genes were shown to be disorder-specific with 620 (78%), 183 (63%), 365 (65%) and 56 (37%) genes unique to ASD, BD, SCZ and OCD, respectively. These results, as well as the results of two- and three-disorder gene overlap, are presented in Fig. 1.
A network diagram showing the
Genetic overlap
Ten genes were identified as commonly associated with the aetiology of ASD, BD, SCZ, and OCD; namely BDNF, CACNA1C, CHRNA7, DRD2, HTR2A, MAOA, MTHFR, NOS1AP, SLC6A3 and TPH2 (Fig. 1). These genes are predominantly involved in substance abuse and addiction, the dopaminergic and serotonergic pathways, the voltage-gated calcium ion channel gene network and folate metabolism (Table 1, Table 3).
Considering each disorder independently this is not too surprising since substance abuse (alcoholism,
Conclusions
Neuropsychiatric disorders are complex in nature and consequently variation within many genes is expected to contribute to their aetiology (Visscher et al., 2012). Genetic overlap between ASD, BD, SCZ and OCD suggests common pathways, as well as pathways unique to each disorder. Here genetic overlap between ASD, BD, SCZ and OCD was found to be enriched for the well-characterised dopaminergic and serotonergic pathways, voltage-gated calcium ion channel gene network, and folate metabolism
Conflict of interest
The authors declare no conflict of interest.
Acknowledgements
The work reported here was supported by the following grants provided by the South African National Research Foundation (NRF) i.e. KOC was funded by the Scarce Skills Post-Doctoral Fellowship (grant no. 96833), LW was funded by the Competitive Program for Rated Researchers (grant no. 93498) and the Bioinformatics and Functional Genomics Program (grant no. 93681). These funding sources had no role in study design; in the collection, analysis and interpretation of data; in the writing of the
References (77)
- et al.
SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study
Schizophr. Res.
(2012) - et al.
Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2012) - et al.
Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons
Biol. Psychiatry
(2015) - et al.
High-resolution chromosome ideogram representation of recognized genes for bipolar disorder
Gene
(2016) Signaling mechanisms that coordinate the development and maintenance of dendritic fields
Curr. Opin. Neurobiol.
(2012)- et al.
Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder
Psychiatry Res.
(2017) - et al.
Specific and common genes implicated across major mental disorders: a review of meta-analysis studies
J. Psychiatr. Res.
(2015) - et al.
Imaging genetics in obsessive-compulsive disorder: linking genetic variations to alterations in neuroimaging
Prog. Neurobiol.
(2014) - et al.
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis
Cell
(2003) - et al.
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders
Prog. Neurobiol.
(2015)
Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD)
J. Anxiety Disord.
Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation
Am. J. Hum. Genet.
Nephrin suppresses hippo signaling through the adaptor proteins Nck and WTIP
J. Biol. Chem.
The potential impact of unpublished results
J. Clin. Epidemiol.
The Na,K-ATPase hypothesis for manic-depression. I. General considerations
Med. Hypotheses
Whole genome sequencing in autism identifies hotspots for de novo germline mutation
Cell
Dendritic spine alterations in schizophrenia
Neurosci. Lett.
Regulation of hippo signaling by EGFR-MAPK signaling through Ajuba family proteins
Dev. Cell
Chemical genetic identification of NDR1/2 kinase substrates AAK1 and Rabin8 uncovers their roles in dendrite arborization and spine development
Neuron
A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)
Am. J. Med. Genet. A
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
Analysis of Shared Heritability in Common Disorders of the Brain
The intricate regulatory mechanisms of lithium on the NA+/K+ ATPase activity and redox balance in bipolar mood disorders
J. Evol. Res. Med. Biochem.
Tobacco smoking is associated with psychotic experiences in the general population of South London
Psychol. Med.
Obsessive-compulsive disorder
J. Pharm. Pract.
High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders
Int. J. Mol. Sci.
Currently recognized genes for schizophrenia: high-resolution chromosome ideogram representation
Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet.
Methamphetamine use and schizophrenia: a population-based cohort study in California
Am. J. Psychiatry
Does dopamine play a role in schizophrenia?
Psychol. Med.
Genetic overlap between autism, schizophrenia and bipolar disorder
Genome Med.
Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive-compulsive disorder in adults: a preliminary case-controlled study
Psychopathology
Obsessive-compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study
Schizophr. Bull.
Genetic relationship between schizophrenia and nicotine dependence
Sci. Rep.
NOS1AP functionally associates with YAP to regulate hippo signaling
Mol. Cell. Biol.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Nat. Genet.
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
Lancet Lond. Engl.
The tumour suppressor hippo acts with the NDR kinases in dendritic tiling and maintenance
Nature
Shared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap
Cited by (63)
The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism
2024, Progress in Neuro-Psychopharmacology and Biological PsychiatryRisk of psychiatric comorbidity with autism spectrum disorder and its association with diagnosis timing using a nationally representative cohort
2023, Research in Autism Spectrum DisordersObsessive-compulsive symptoms in first episode psychosis and risk states: Systematic review with meta-analysis
2023, Schizophrenia Research